NYSE · ZEPP
Zepp Health financials
$3.96+1.80%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q4 '25 Dec 31 | Q4 '24 Dec 31 | Q4 '23 Dec 31 | Q4 '22 Dec 31 | Q4 '21 Dec 31 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Gross margin | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | — | — | — | — | — |
| Net margin | — | — | — | — | — |
| Diluted EPS | — | — | — | — | — |
| EBITDA | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating cash flow | — | — | — | — | — |
| Free cash flow | — | — | — | — | — |
| Diluted shares | 254.4M | 258.9M | 243.1M | 246.3M | 66.1M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $57.0M | $91.1M | $133.7M | $886.6M | $230.4M |
| Short-term investments | $0.00 | $997.0K | $5.2M | $34.3M | $3.0M |
| Total debt | $226.9M | $178.8M | $188.7M | $1.65B | $186.5M |
| Total assets | $564.8M | $528.6M | $635.5M | $5.27B | $955.0M |
| Total liabilities | $350.3M | $275.9M | $282.8M | $2.58B | $494.6M |
| Shareholders' equity | $214.5M | $252.7M | $352.8M | $2.68B | $460.3M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology